PULMONARY FIBROSIS FOUNDATION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$15,320,155
Investments
51%
Cash & Equivalents
35%
Other Assets
8%
Receivables (Non-Related)
3%
Prepaid Expenses
3%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$3,865,441
Deferred Revenue
38%
Other Liabilities
31%
Grants Payable
17%
Payables & Accruals
14%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$6,548,446
$5,406,039
-17%
Receivables (Non-Related)
$689,273
$460,547
-33%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$826,272
$393,720
-52%
Investments
$7,056,650
$7,737,418
+10%
Property, Plant, & Equipment (net)
$58,836
$33,409
-43%
Other Assets
$1,614,968
$1,289,022
-20%
Total Assets
$16,794,445
$15,320,155
-9%
Liabilities
2023
2024
Change
Payables & Accruals
$1,468,962
$541,335
-63%
Grants Payable
$388,687
$645,813
+66%
Deferred Revenue
$1,776,594
$1,475,869
-17%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,424,953
$1,202,424
-16%
Total Liabilities
$5,059,196
$3,865,441
-24%
Net assets
2023
2024
Change
Restricted Net Assets
$3,925,677
$3,017,922
-23%
Unrestricted Net Assets
$7,809,572
$8,436,792
+8%
Net assets
2023
2024
Change
Net assets
+$11,735,249
+$11,454,714
-2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)